相关实验视频
Updated: Jun 8, 2025

Transcutaneous Assessment of Renal Function in Conscious Rodents
Published on: March 26, 2016
在中度功能障碍中对Trofinetide进行生理学基础的药理动力学建模,用于第一阶段临床研究,用模型验证进行剂量选择
Mona Darwish1, Thomas C Marbury2, Rene Nunez3
1Acadia Pharmaceuticals Inc, 12830 El Camino Real, Suite 400, San Diego, CA, 92130, USA. mdarwish@acadia-pharm.com.
对于雷特综合征的治疗方法托菲尼提德 (Trofinetide),在中度功能障碍的情况下需要调整剂量. 50%的剂量减少通过药理动力学建模和一期研究得到了验证,没有显示出新的安全问题.
科学领域:
- 药理学 药理学是指药理学的学科.
- 临床药理学 临床药理学
- 患有功能障碍的人
背景情况:
- 雷特综合征 (RTT) 治疗中,托菲尼提德通过脏分泌.
- 在功能障碍中评估托菲尼提德暴露对于安全剂量至关重要.
- 药物动力学建模有助于在特殊人群中找到剂量.
研究的目的:
- 评估托菲尼提德的药理动力学,安全性和适度功能障碍患者的耐受性.
- 验证基于生理学的药理动力学 (PBPK) 模型对剂量调整的预测.
- 在健康人群中比较托菲尼提德暴露与中度功能障碍的人群.
主要方法:
- 一个PBPK模型预测了针对功能障碍阶段的剂量调整.
- 一个第1阶段的开放性研究评估了对健康 (n=10) 和中度功能障碍 (n=10) 参与者的托菲尼提德暴露.
- 观察到的暴露 (AUCinf,Cmax) 与PBPK模型预测进行了比较.
主要成果:
- 剂量正常化的Cmax在两组之间是可比的;AUCinf在中度功能障碍中高出约2倍.
- 观察到的暴露与PBPK模型预测密切一致.
- 不良事件是可比的,没有发现新的安全问题.
结论:
- PBPK建模准确地预测了中度功能障碍的托菲尼提德剂量减少50%.
- 第1期研究结果验证了预测的剂量减少.
- 托菲尼提德在中度功能障碍患者中表现出良好的安全性.
相关概念视频
Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
A recent model describes pravastatin's hepatobiliary excretion,...
Model Approaches for Pharmacokinetic Data: Physiological Models
Factors Affecting Renal Clearance: Renal Impairment
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Physiological Pharmacokinetic Models: Blood Flow-Limited Versus Diffusion-Limited Models

